🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Active Not Recruiting
Location
Shanghai Dermatology Hospital
Start Date
2024-09-23
Trial ID
NCT06554847
Treatments Being Tested
This phase I study will evaluate the safety and tolerability of an autologo...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01022255
Treatments Being Tested
The goal of this randomized clinical trial is to learn if topical treatment...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2025-08-25
Trial ID
NCT06830863
Use of PTH (1-84) a recombinant hormone in 25 µg or 50 µg doses for the tre...
Status
Completed
Location
Advance Medical Research LLC
Start Date
2011-02-09
Trial ID
NCT01268098
Treatments Being Tested
RATIONALE: Radioactive iodine uses radiation to kill tumor cells. Giving io...
Status
Unknown
Location
Sussex Cancer Centre at Royal Sussex County Hospital
Start Date
2006-11
Trial ID
NCT00415233
Treatments Being Tested
A multicenter, randomized, double-blind, placebo-controlled phase III clini...
Status
Unknown
Location
Shanghai Sixth People's Hospital
Start Date
2019-06-30
Trial ID
NCT05060406
Treatments Being Tested
This first-in-human open-label, multi center, dose-escalation and expansion...
Status
Terminated
Location
Liverpool Hospital
Start Date
2021-10-29
Trial ID
NCT05073484
This study is an Expanded Access Protocol (EAP) of JZP458 in participants w...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04943952
Treatments Being Tested
The risk of severe course of SARS-CoV-2 infection in people with Down Syndr...
Status
Unknown
Location
UMC utrecht
Start Date
2021-02-03
Trial ID
NCT05145348
We define refractory nasopharyngeal carcinoma as the following: recurrence ...
Status
Unknown
Location
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center
Start Date
2015-07
Trial ID
NCT02590133
Treatments Being Tested